Researchers examined the best approach for treating papillary thyroid microcarcinoma, offering choices like radiofrequency ablation, active surveillance, or surgery. Their mathematical model assessed the likelihood of cancer progression, the need for thyroid replacement therapy, and treatment complications. Radiofrequency ablation outperformed active surveillance in averting progression and the need for lifelong thyroid therapy. Yet, the cost per progression-avoided was quite high, making radiofrequency ablation more practical for younger patients, while cost issues may limit its routine use among those with thyroid microcarcinomas.
Journal Article by Carlisle KM, Brown JP (…) Hu Y et 5 al. in BMC Surg
Copyright © 2023 Elsevier Inc. All rights reserved.